(Hong Kong, 14 January 2010) – Lee’s Pharmaceutical Holdings Limited (GEM Stock: 8221; Website: www.leespharm.com) (“Leespharm”) announced today that the Group has successfully obtained the renewal of Imported Drug License (“IDL”) for marketing of Ferplex® (Iron Proteinsuccinylate Oral Solution), in the People’s Republic of China.